Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-16
1997-04-29
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514300, 514302, 546113, 546114, 546115, 546122, A61K 31435, C07D49504
Patent
active
056249349
ABSTRACT:
The present invention provides novel HIV protease inhibitors, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection.
REFERENCES:
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5484926 (1996-01-01), Dressman et al.
Roberts N.A. et al., Science, 248, 358-361 (20 Apr. 1990).
Thaisrivongs S. et al., J. Med. Chem., 34, 2344-2356 (1991).
Ghosh A.K. et al., J. Med. Chem., 37, 1177-1188 (1994).
Ghosh A.K. et al., J. Med. Chem., 37, 2506-2508 (1994).
Kim B.M., et al., Tetrahedron Letters, 34(41), 6517-6520 (1993).
Hornback William J.
Munroe John E.
Shepherd Timothy A.
Dentz Bernard
Eli Lilly and Company
LandOfFree
Protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705946